Reply to Tarchini
To the Editor-We appreciate the interest in the article and the comments. As was mentioned in the letter by Dr Tarchini [1] , our article [2] specified very clearly the limitations to the analysis, and we agree that these limitations should be applied to all post hoc analyses. Several additional points require clarification. First, the analysis was not a meta-analysis; it was a pooled analysis of secondary bacteremia in tigecycline's approved indications. Second, we believe that the comments by Dr Tarchini [1] on the quality of the data and the interpretation of the data are not accurate. The purpose of the randomized, double-blind clinical trials was to determine the safety and efficacy of tigecycline empirical therapy with appropriate and approved comparators for each given indication. Given the serum pharmacokinetic data of tigecycline, the purpose of the pooled analysis was to determine the safety and efficacy of tigecycline empirical therapy in the subset of subjects with secondary bacteremia within the approved indications. The advantages and disadvantages of individual antibiotic choices for definitive therapy were not the primary aim of the clinical trials or the pooled analysis. In addition, the comment by Dr Tarchini [1] regarding empirical levofloxacin therapy for the treatment of communityacquired pneumonia is not accurate. Levofloxacin is approved for 7-14 days therapy at the 500-mg dose, and this was the recommended dose at the time the trials [3, 4] were designed and initiated. We believe that our statement regarding the similarity in cure rates between empirical tigecycline therapy and appropriate and approved empirical comparative therapy in subjects with secondary bacteremia is accurate [2] .
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All unduplicated patients that were active at any time between January and August 2009 and whose name appeared on the 104 day report were extracted from the EMR. The data elements that were analyzed were (1) what percentage of individuals who were on the 104 day report at one time do not appear on the report again-that is, who made a follow-up appointment and were seen; and (2) of those who still appear on the 104 day report, how many have future appointments or no appointments.
The search yielded 3354 of 8418 unduplicated patients on the 104 day reports who were called. Two thousand eighty (62%) of the 3354 patients were not on the 104-day report anymore; thus, they had undergone follow-up with their care providers. One hundred seventy (5.1%) were inactive but were called and declined to retain to care. Seventeen (0.5%) of the patients had died. One thousand eightyseven patients (32%) were still on the 104 day report, but one-third (n p 331) of these patients had an appointment scheduled for the near future.
Given our experience and these findings, having a patient enrolled in the same provider roster and allowing better patient-provider relationship might yield greater retention in care, as would calls from the medical provider to the patient in the event of a missed appointment. Additional prospective studies are urgently needed.
Q Fever, Free Amoeba, and Air Conditioning
To the Editor-I congratulate the team of Amitai et al [1] on their investigation of an epidemic of Q fever in a school in Israel. This work is remarkable because, for the first time, to the best of my knowledge, it evokes the role of the air conditioning as a potential source of the Q fever. This assumption deserves to be considered in the context of a reflection on diseases transmitted by air conditioning and, more generally, on diseases caused bacteria hosted by the free amoebas of water present in air conditioning devices and cooling towers. Legionnaires disease was the first disease recognized to have free amoebas as reservoirs, which explained persistence of Legionella pneumophila in water supply networks, in the circuits of air conditioning, and in hospitals and hotels. The resistance of the amoebas to the process of sterilization explains the difficulty in eliminating L. pneumophila from water circuits [2] . In recent years, there has been a considerable increase of the number of bacteria identified in amoebas, which used free amoeba as reservoir and Trojan horse to infect human beings [2, 3] . In an interesting way, certain bacterial pathogens transmissible by aerosols can be found in the free amoebas of water: Legionella species, but also Fransicella tularensis, Chlamydia-related organisms, Mycobacterium species other than Mycobacterium tuberculosis [2, 3] , and Coxiella burnetii. C. burnetii is mainly transmitted by aerosols [1] and has a capacity to survive in the free amoeba [4] , which led researchers to suspect that intra-amoebal survival had played a role in the selection of the pathogenicity of these bacteria for humans. Moreover, C. burnetii and L. pneumophila obviously had exchanged genes in the amoebas [5] . On the basis of these data, one may suspect that C. burnetii was a candidate to be transmitted by air conditioning. Finally, amoebas of water are also used as vehicles and reservoirs by many mycobacteria that are at the origin of postoperative nosocomial infections of the skin.
In conclusion, the association with Q fever and air conditioning is not really a surprise and makes sense if it is acknowledged that C. burnetii can survive in amoebas and, thus, be conveyed by water pipelines. The capacity of C. burnetii to be transmitted by aerosol in air conditioning mean that, like other bacteria resisting the phagocytic capabilities of the free-living amoebas, it has the potential to determine infections by way of aerosols. Moreover, free-living protists (including amoebas), by organizing gene exchanges of intracellular organisms, are participating in the creation of new genomic repertoires and may help in the creation of new respiratory pathogens [6] . I suggest that the amoeba-resisting organisms, including C. burnetii [7] , should be tested if unexplained cases of pneumonia are observed in patients exposed to air conditioning, including patients with nosocomial pneumonia.
